The U.S. subsidiaries of French pharmaceutical giant Sanofi will pay $109 million to settle allegations they gave kickbacks to induce doctors to buy and prescribe Hyalgan, a knee injection.
The Justice Department alleges that Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LLC violated the False Claims Act by giving doctors thousands of free units of Hyalgan as the drug faced pressure from a lower-priced competitor. The agency also alleges Sanofi submitted false reports on the average sale price of Hyalgan that excluded the free units, causing Medicare and other federal health care programs to reimburse the company at inflated rates. The company said it voluntarily stopped sampling Hyalgan in 2009.
JOIN THE DISCUSSION | Register here
We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.